Global News

Verified Clinical Trials partners with SAFE-BioPharma

Friday, July 26, 2013 09:00 AM

Verified Clinical Trials, whose technology helps eliminate multiple enrollments by clinical trial volunteers and provides Medicare Secondary Payer Law compliance strategies, will offer its services with SAFE-BioPharma, a global digital identity management and signature standard used by many of the world’s largest biopharmaceutical companies. The company also has joined the SAFE-BioPharma Vendor Partner program, providing it with direct access to decision-makers in SAFE-BioPharma’s member companies.

More... »

University of Edinburgh, Biogen Idec partner

Wednesday, July 24, 2013 02:35 PM

The University of Edinburgh and Massachusetts-based biotech Biogen Idec have partnered to research multiple sclerosis and motor neurone disease and identify drug compounds for potential treatments. The initiative is funded by Biogen Idec, which develops therapies for neurological disorders and has a portfolio of treatments for patients with multiple sclerosis.

More... »

CROS NT joins DatatrakConnect

Wednesday, July 24, 2013 02:18 PM

Datatrak International, a developer of eClinical technologies, has announced international CRO CROS NT has joined the DatatrakConnect partner program, a collaboration between companies to accelerate the drug development process.

More... »

Quest PharmaTech, AD Biotech form joint cancer venture

Wednesday, July 24, 2013 02:15 PM

Quest PharmaTech, a pharmaceutical company developing and commercializing cancer treatment products, has entered into a relationship with Korean-based AD Biotech to share research and technology development resources to co-develop technologies of both companies.

More... »

OncoGenex completes phase II enrollment

Wednesday, July 24, 2013 12:35 PM

OncoGenex Pharmaceuticals has completed enrollment in Borealis-1, a company-sponsored, randomized, placebo-controlled phase II trial of OGX-427 in combination with first-line gemcitabine and cisplatin in patients with metastatic bladder cancer.

More... »

UofL now enrolling patients in phase III stem cell trial

Wednesday, July 24, 2013 11:34 AM

The University of Louisville is now enrolling qualifying patients in a nationwide phase III clinical trial to study whether a patient’s own stem cells could help lessen the effects of angina.

More... »

Astellas receives FDA approval of ASTAGRAF XL

Wednesday, July 24, 2013 10:15 AM

Astellas Pharmasaid the FDA has approved ASTAGRAF XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction.

More... »

CRO Solutions launches VxP Pharma

Wednesday, July 24, 2013 10:00 AM

CRO Solutions has launched VxP Pharma, a wholly-owned subsidiary. VxP Pharma offers the combined services of the independently owned and operated "niche" CROs of its parent company. VxP Pharma will offer pharmaceutical development services and technical support from discovery through phase IIb.

More... »

Frontage Laboratories names new head of global CMC services

Wednesday, July 24, 2013 09:43 AM

Frontage Laboratories has appointed Dr. Cheryl Li senior vice president, Global CMC Services.  The division offers an integrated service portfolio ranging from dosage form product development, contract manufacturing, pharmaceutical analysis and organic syntheses to CMC strategy consulting. Li’s position is an initial step of Frontage’s corporate strategic expansion in CMC infrastructure to meet growing development needs in novel drugs, generic products and biosimilars.

More... »

Aesica, QRxPharma collaborate to promote Stealth Beadlets

Wednesday, July 24, 2013 09:30 AM

Aesica Pharmaceuticals, a global contract development and manufacturing organization (CDMO), has partnered with pharmaceutical company QRxPharma to globally promote QRxPharma’s proprietary Stealth Beadlets abuse deterrence technology.

More... »